Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir. (Record no. 17540406)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01982 a2200553 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515094457.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200804s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1386-6532 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.jcv.2007.10.003 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Vergani, Barbara |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20080422 |
245 00 - TITLE STATEMENT | |
Title | Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology |
Date of publication, distribution, etc. | Feb 2008 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 154-9 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-HIV Agents |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Atazanavir Sulfate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Resistance, Viral |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Evolution, Molecular |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genotype |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HIV Infections |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HIV Protease |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HIV Protease Inhibitors |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | HIV-1 |
General subdivision | classification |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Molecular Sequence Data |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mutation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oligopeptides |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phenotype |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Phylogeny |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyridines |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sequence Analysis, DNA |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cicero, Mirko Lo |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Vigano', Ottavia |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sirianni, Francesca |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ferramosca, Stefania |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Vitiello, Paola |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Di Vincenzo, Paola |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pia De Pasquale, Maria |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Galli, Massimo |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rusconi, Stefano |
773 0# - HOST ITEM ENTRY | |
Title | Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology |
Related parts | vol. 41 |
-- | no. 2 |
-- | p. 154-9 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.jcv.2007.10.003">https://doi.org/10.1016/j.jcv.2007.10.003</a> |
Public note | Available from publisher's website |
No items available.